Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06639711
PHASE1/PHASE2

Taurine Eye Drops May Prevent the Progression of Cataract

Sponsor: University Of Anbar

View on ClinicalTrials.gov

Summary

The aim of the current intervention study is to determine the effectiveness of taurine containing eye drops (available under brand name VIZILOTON) to prevent the progression of grade I and II senile cataract. This study could answer: * Dose continuous use of taurine-containing eye drops could prevent further deterioration of vision in mild cases of cataract? * The acceptance/ compliance of participants to taurine-containing eye drops. * Could long-term use of taurine-containing eye drops cause adverse effect(s)? Participants will: * Take taurine-containing eye drops (VIZILOTON eye drops) 4 times a day for one year. * Visit eye clinic every 3 months for assessment and visual examination. * Keep notes for their symptoms and their adherence to treatment.

Official title: Taurine Affects the Progression of Senile Cataract: a Single-arm Pre-post Intervention Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2023-07-10

Completion Date

2024-12-20

Last Updated

2024-12-09

Healthy Volunteers

No

Conditions

Interventions

DRUG

Taurine

Taurine-containing eye drops (VIZILOTON) are applied 4 times daily for a period of one year

Locations (1)

Al-Nahrain Eye Clinics

Ramadi, Al-Anbar Governorate, Iraq